Cobinamide is Superior to Other Treatments in a Mouse Model of Cyanide Poisoning

Overview

Journal Clin Toxicol (Phila)

Publisher Informa Healthcare

Specialty Toxicology

Date 2010 Aug 14

PMID 20704457

Citations 25

Authors

Adriano Chan

Maheswari Balasubramanian

William Blackledge

Othman M Mohammad

Luis Alvarez

Gerry R Boss

Timothy D Bigby

Affiliations

Soon will be listed here.

Abstract

Context: Cyanide is a rapidly acting cellular poison, primarily targeting cytochrome c oxidase, and is a common occupational and residential toxin, mostly via smoke inhalation. Cyanide is also a potential weapon of mass destruction, with recent credible threats of attacks focusing the need for better treatments, as current cyanide antidotes are limited and impractical for rapid deployment in mass casualty settings.

Objective: We have used mouse models of cyanide poisoning to compare the efficacy of cobinamide (Cbi), the precursor to cobalamin (vitamin B(12)), to currently approved cyanide antidotes. Cbi has extremely high affinity for cyanide and substantial solubility in water.

Materials And Methods: We studied Cbi in both an inhaled and intraperitoneal model of cyanide poisoning in mice.

Results: We found Cbi more effective than hydroxocobalamin, sodium thiosulfate, sodium nitrite, and the combination of sodium thiosulfate-sodium nitrite in treating cyanide poisoning. Compared to hydroxocobalamin, Cbi was 3 and 11 times more potent in the intraperitoneal and inhalation models, respectively. Cobinamide sulfite (Cbi-SO(3)) was rapidly absorbed after intramuscular injection, and mice recovered from a lethal dose of cyanide even when given at a time when they had been apneic for over 2 min. In range-finding studies, Cbi-SO(3) at doses up to 2000 mg/kg exhibited no clinical toxicity.

Discussion And Conclusion: These studies demonstrate that Cbi is a highly effective cyanide antidote in mouse models, and suggest it could be used in a mass casualty setting, because it can be given rapidly as an intramuscular injection when administered as Cbi-SO(3). Based on these animal data Cbi-SO(3) appears to be an antidote worthy of further testing as a therapy for mass casualties.

Citing Articles

Cobinamide is a strong and versatile antioxidant that overcomes oxidative stress in cells, flies, and diabetic mice.

Chang S, Tat J, Pal China S, Kalyanaraman H, Zhuang S, Chan A PNAS Nexus. 2022; 1(4):pgac191.

PMID: 36276587 PMC: 9578022. DOI: 10.1093/pnasnexus/pgac191.

Identification of Platinum(II) Sulfide Complexes Suitable as Intramuscular Cyanide Countermeasures.

Behymer M, Mo H, Fujii N, Suresh V, Chan A, Lee J Chem Res Toxicol. 2022; 35(11):1983-1996.

PMID: 36201358 PMC: 9682522. DOI: 10.1021/acs.chemrestox.2c00157.

Methyl mercaptan gas: mechanisms of toxicity and demonstration of the effectiveness of cobinamide as an antidote in mice and rabbits.

Philipopoulos G, Tat J, Chan A, Jiang J, Mukai D, Burney T Clin Toxicol (Phila). 2022; 60(5):615-622.

PMID: 34989638 PMC: 9662850. DOI: 10.1080/15563650.2021.2017949.

Synthesis, Optimization, and Biological Evaluation of Corrinated Conjugates of the GLP-1R Agonist Exendin-4.

Tinsley I, Borner T, Swanson M, Chepurny O, Doebley S, Kamat V J Med Chem. 2021; 64(6):3479-3492.

PMID: 33677970 PMC: 8279408. DOI: 10.1021/acs.jmedchem.1c00185.

Oral Glycine and Sodium Thiosulfate for Lethal Cyanide Ingestion.

Brenner M, Azer S, Oh K, Han C, Lee J, Mahon S J Clin Toxicol. 2017; 7(3).

PMID: 28868209 PMC: 5578424. DOI: 10.4172/2167-7972.1000355.

References

Moore S, Ho I, HUME A . Severe hypoxia produced by concomitant intoxication with sublethal doses of carbon monoxide and cyanide. Toxicol Appl Pharmacol. 1991; 109(3):412-20. DOI: 10.1016/0041-008x(91)90004-x. View

Gentry R, Rappaport M, DOLE V . Serial determination of plasma ethanol concentrations in mice. Physiol Behav. 1983; 31(4):529-32. DOI: 10.1016/0031-9384(83)90077-x. View

NORRIS J, Moore S, HUME A . Synergistic lethality induced by the combination of carbon monoxide and cyanide. Toxicology. 1986; 40(2):121-9. DOI: 10.1016/0300-483x(86)90073-9. View

Lundquist P, Rosling H, SORBO B . Determination of cyanide in whole blood, erythrocytes, and plasma. Clin Chem. 1985; 31(4):591-5. View

Evans C . COBALT COMPOUNDS AS ANTIDOTES FOR HYDROCYANIC ACID. Br J Pharmacol Chemother. 1964; 23:455-75. PMC: 1703995. DOI: 10.1111/j.1476-5381.1964.tb01603.x. View

Alarie Y . Toxicity of fire smoke. Crit Rev Toxicol. 2002; 32(4):259-89. DOI: 10.1080/20024091064246. View

Sharma V, Pilz R, Boss G, Magde D . Reactions of nitric oxide with vitamin B12 and its precursor, cobinamide. Biochemistry. 2003; 42(29):8900-8. DOI: 10.1021/bi034469t. View

BOXER G, RICKARDS J . Determination of thiocyanate in body fluids. Arch Biochem Biophys. 1952; 39(2):292-300. DOI: 10.1016/0003-9861(52)90338-x. View

Brenner M, Mahon S, Lee J, Kim J, Mukai D, Goodman S . Comparison of cobinamide to hydroxocobalamin in reversing cyanide physiologic effects in rabbits using diffuse optical spectroscopy monitoring. J Biomed Opt. 2010; 15(1):017001. PMC: 2816993. DOI: 10.1117/1.3290816. View

10.

Broderick K, Potluri P, Zhuang S, Scheffler I, Sharma V, Pilz R . Cyanide detoxification by the cobalamin precursor cobinamide. Exp Biol Med (Maywood). 2006; 231(5):641-9. DOI: 10.1177/153537020623100519. View

11.

WAY J . Cyanide intoxication and its mechanism of antagonism. Annu Rev Pharmacol Toxicol. 1984; 24:451-81. DOI: 10.1146/annurev.pa.24.040184.002315. View

12.

Borron S, Baud F, Barriot P, Imbert M, Bismuth C . Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007; 49(6):794-801, 801.e1-2. DOI: 10.1016/j.annemergmed.2007.01.026. View

13.

Gracia R, Shepherd G . Cyanide poisoning and its treatment. Pharmacotherapy. 2005; 24(10):1358-65. DOI: 10.1592/phco.24.14.1358.43149. View

14.

Broderick K, Balasubramanian M, Chan A, Potluri P, Feala J, Belke D . The cobalamin precursor cobinamide detoxifies nitroprusside-generated cyanide. Exp Biol Med (Maywood). 2007; 232(6):789-98. View

15.

Scheffler I . Mitochondria make a come back. Adv Drug Deliv Rev. 2001; 49(1-2):3-26. DOI: 10.1016/s0169-409x(01)00123-5. View

16.

Silverman S, Purdue G, Hunt J, Bost R . Cyanide toxicity in burned patients. J Trauma. 1988; 28(2):171-6. DOI: 10.1097/00005373-198802000-00007. View

17.

Gewitz H, Pistorius E, Voss H, Vennesland B . Cyanide formation in preparations from Chlorella vulgaris Beijerinck: Effect of sonication and amygdalin addition. Planta. 2014; 131(2):145-8. DOI: 10.1007/BF00389986. View

18.

Doi M, Ikeda K . Postanesthetic respiratory depression in humans: a comparison of sevoflurane, isoflurane and halothane. J Anesth. 1987; 1(2):137-42. DOI: 10.1007/s0054070010137. View

19.

Broderick K, Singh V, Zhuang S, Kambo A, Chen J, Sharma V . Nitric oxide scavenging by the cobalamin precursor cobinamide. J Biol Chem. 2005; 280(10):8678-85. DOI: 10.1074/jbc.M410498200. View

20.

Bruce R . An up-and-down procedure for acute toxicity testing. Fundam Appl Toxicol. 1985; 5(1):151-7. DOI: 10.1016/0272-0590(85)90059-4. View